Surrozen (SRZN) Other Non-Current Assets (2020 - 2026)

Surrozen (SRZN) recorded quarterly Other Non-Current Assets of $34000.0 in Q1 2026, down 26.09% quarter-over-quarter from $46000.0 in Q4 2025, and down 95.06% on a YoY basis from $688000.0 in Q1 2025.

Surrozen (SRZN) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Surrozen's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $34000.0 for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 95.06% year-over-year to $34000.0; the TTM figure through Mar 2026 stood at $34000.0 (down 95.06% YoY), while the FY2025 annual figure was $46000.0, down 86.1% from the prior year.
  • Other Non-Current Assets was $34000.0 for Q1 2026 at Surrozen, down from $46000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $846000.0 in Q3 2022 to a low of $34000.0 in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $443882.4 across 5 years, with a median of $405000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets jumped 108.89% in 2022, then tumbled 95.06% in 2026.
  • A 5-year view of Other Non-Current Assets shows it stood at $405000.0 in 2022, then soared by 69.88% to $688000.0 in 2023, then plunged by 51.89% to $331000.0 in 2024, then slumped by 86.1% to $46000.0 in 2025, then declined by 26.09% to $34000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $34000.0 (Q1 2026), $46000.0 (Q4 2025), and $64000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 60,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - 34,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 34,000.00
Dec 31, 2025 46,000.00
Sep 30, 2025 64,000.00
Jun 30, 2025 688,000.00
Mar 31, 2025 688,000.00
Dec 31, 2024 331,000.00
Sep 30, 2024 688,000.00
Jun 30, 2024 373,000.00
Mar 31, 2024 688,000.00
Dec 31, 2023 688,000.00
Sep 30, 2023 376,000.00
Jun 30, 2023 405,000.00
Mar 31, 2023 416,000.00
Dec 31, 2022 405,000.00
Sep 30, 2022 846,000.00
Jun 30, 2022 405,000.00
Mar 31, 2022 405,000.00
Dec 31, 2021 549,000.00
Sep 30, 2021 405,000.00
Dec 31, 2020 39,000.00